You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The company has made agreements with two cancer diagnostics firms — GenomeDx, and Cynvenio — bundling its hereditary germline analysis with their somatic tests.
Over the next month the company plans to expand its preconception screening test, which it launched widely earlier this year, by adding about 90 X-linked disorders.
The addition of the patient-facing family history platform will expand and enhance Invitae's existing genome management support services, the company said.
One group pointed out differences between study group characteristics, while the other wondered about the role of patient preference.
The new assay, called the CellMax-DNA Genetic Cancer Risk Test, will complement CellMax Life's planned slate of liquid biopsy assays for early cancer detection.
The results showed overall high concordance between test results and whether patients received chemotherapy, with some relevant exceptions.
Genomed, based in Warsaw, offers sequencing-based diagnostic and research services and brought BGI's noninvasive prenatal NIFTY test in house last year.